Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.36 |
| ▸ | TET3 | O43151 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL502499 | 0.83 | — | — | |
| SCHEMBL29001668 | 0.76 | OR51E2 (0.52) | SMN1; SMN2TET2TET3TET1SLC22A6 | |
| Acetaldehyde SCHEMBL18398677 | 0.75 | GAPDH (0.33) | GPR84 | |
| SCHEMBL10126335 | 0.75 | TRPA1 (0.32) | — | |
| SCHEMBL5753841 | 0.74 | FOLH1 (0.32) | — | |
| SCHEMBL2884275 | 0.72 | TSHR (0.36) | GPR84 | |
| SCHEMBL2884280 | 0.72 | TSHR (0.36) | GPR84 | |
| SCHEMBL4642136 | 0.72 | — | — | |
| SCHEMBL9599979 | 0.72 | TSHR (0.36) | GPR84 | |
| Oxalic Acid SCHEMBL28235580 | 0.72 | OR51E2 (0.48) | SMN1; SMN2TET2TET3TET1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120052028-A1 | CINNAMIC ACID ASCORBATES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052028-A1 | CINNAMIC ACID ASCORBATES | PROC, C1S, NISCH | SMN1; SMN2 3843/4885TET2 72/4885TET3 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.